Wealth Management Associates, Inc. Arbutus Biopharma Corp Transaction History

Wealth Management Associates, Inc.

$233 Billion
Q1 2025

A detailed history of Wealth Management Associates, Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Wealth Management Associates, Inc. holds 96,420 shares of ABUS stock, worth $323,971. This represents 0.14% of its overall portfolio holdings.

Number of Shares

96,420

Previous 61,020 58.01%

Holding current value

$323,971

Previous $200 Million 68.65%

% of portfolio

0.14%

Previous 0.09%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 28, 2025	BUY	$3.06 - $3.59 $108,324 - $127,086	35,400 Added 58.01%	96,420 $337 Million
Q4 2024 May 28, 2025	BUY	$3.18 - $4.2 $20,670 - $27,300	6,500 Added 11.92%	61,020 $200 Million
Q3 2024 May 28, 2025	BUY	$3.12 - $4.56 $14,664 - $21,431	4,700 Added 9.43%	54,520 $210 Million
Q1 2024 May 28, 2025	BUY	$2.26 - $2.92 $4,067 - $5,256	1,800 Added 3.75%	49,820 $154 Million
Q4 2023 May 28, 2025	SELL	$1.69 - $2.54 $11,154 - $16,764	-6,600 Reduced 12.08%	48,020 $120 Million
Q3 2023 May 28, 2025	BUY	$1.9 - $2.27 $9,500 - $11,350	5,000 Added 10.08%	54,620 $111 Million
Q1 2023 May 28, 2025	BUY	$2.23 - $3.1 $780 - $1,085	350 Added 0.71%	49,620 $150 Million
Q4 2022 May 28, 2025	BUY	$1.91 - $2.85 $16,044 - $23,940	8,400 Added 20.55%	49,270 $115 Million
Q3 2022 May 28, 2025	BUY	$1.88 - $2.88 $21,056 - $32,256	11,200 Added 37.75%	40,870 $78.1 Million
Q2 2022 May 28, 2025	BUY	$1.98 - $3.17 $14,850 - $23,775	7,500 Added 33.83%	29,670 $80.4 Million
Q1 2022 May 28, 2025	BUY	$2.42 - $3.98 $8,712 - $14,328	3,600 Added 19.39%	22,170 $66.1 Million
Q4 2021 May 28, 2025	BUY	$3.11 - $4.61 $5,598 - $8,298	1,800 Added 10.73%	18,570 $72.2 Million
Q3 2021 May 28, 2025	SELL	$2.65 - $4.62 $1,855 - $3,234	-700 Reduced 4.01%	16,770 $71.9 Million
Q2 2021 May 28, 2025	SELL	$2.5 - $3.51 $29,250 - $41,067	-11,700 Reduced 40.11%	17,470 $52.9 Million
Q1 2021 May 28, 2025	SELL	$3.14 - $4.84 $7,536 - $11,616	-2,400 Reduced 7.6%	29,170 $97.1 Million
Q4 2020 May 28, 2025	BUY	$2.76 - $4.97 $87,133 - $156,902	31,570 New	31,570 $112 Million

Others Institutions Holding ABUS

# of Institutions

191

Shares Held

111M

Call Options Held

866K

Put Options Held

608K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $504M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Management Associates, Inc. with notifications on news.

Account

Wealth Management Associates, Inc. Arbutus Biopharma Corp Transaction History